Shandong Sinoglory Health Food Co., Ltd (SHA:603182)
China · Delayed Price · Currency is CNY 15.26
+0.42 (2.83%)
May 8, 2026, 4:00 PM EDT
SHA:603182 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,456 | 1,386 | 1,484 | 1,690 | 1,609 | 1,230 |
Other Revenue | - | - | 4.19 | 4.09 | 3.91 | 4.28 |
| 1,456 | 1,386 | 1,488 | 1,695 | 1,613 | 1,234 | |
Revenue Growth (YoY) | 0.96% | -6.89% | -12.17% | 5.05% | 30.69% | 27.43% |
Cost of Revenue | 1,280 | 1,204 | 1,309 | 1,486 | 1,405 | 1,075 |
Gross Profit | 175.95 | 181.78 | 179.49 | 208.37 | 208.37 | 159.24 |
Selling, General & Admin | 41.56 | 41.86 | 41.52 | 42.62 | 38.25 | 32.91 |
Research & Development | 10.5 | 10.44 | 10.41 | 9.9 | 16.67 | 17.13 |
Other Operating Expenses | 3.69 | 3.77 | 4.61 | 6.3 | 8.45 | 5.14 |
Operating Expenses | 55.75 | 56.07 | 49.28 | 67.16 | 63.67 | 56.74 |
Operating Income | 120.2 | 125.71 | 130.21 | 141.21 | 144.69 | 102.5 |
Interest Expense | -0.13 | - | -0.63 | -1.56 | -3.18 | -3.98 |
Interest & Investment Income | - | 0.02 | 4.36 | 7.13 | 2.77 | 2.84 |
Currency Exchange Gain (Loss) | - | - | 5.66 | 1.88 | 6.98 | -2.31 |
Other Non Operating Income (Expenses) | 1.07 | 3.57 | -0.47 | -0.36 | -4.31 | -0.27 |
EBT Excluding Unusual Items | 121.14 | 129.3 | 139.13 | 148.31 | 146.96 | 98.77 |
Gain (Loss) on Sale of Investments | - | - | - | - | -9.25 | 0.53 |
Gain (Loss) on Sale of Assets | 0.07 | 0.11 | -0.01 | -0.92 | 0.03 | -0.99 |
Asset Writedown | -8.53 | -4.1 | -0.12 | -0.27 | -0.31 | - |
Other Unusual Items | - | - | 3.69 | 1.3 | 10.86 | 3.32 |
Pretax Income | 112.68 | 125.31 | 142.69 | 148.41 | 148.3 | 101.63 |
Income Tax Expense | 26.38 | 30.61 | 33.55 | 38.28 | 33.92 | 22.48 |
Net Income | 86.3 | 94.7 | 109.14 | 110.14 | 114.38 | 79.15 |
Net Income to Common | 86.3 | 94.7 | 109.14 | 110.14 | 114.38 | 79.15 |
Net Income Growth | -24.04% | -13.23% | -0.91% | -3.71% | 44.51% | 6.83% |
Shares Outstanding (Basic) | 163 | 163 | 165 | 164 | 133 | 124 |
Shares Outstanding (Diluted) | 163 | 163 | 165 | 164 | 133 | 124 |
Shares Change (YoY) | -1.21% | -1.26% | 0.59% | 23.59% | 7.54% | 0.21% |
EPS (Basic) | 0.53 | 0.58 | 0.66 | 0.67 | 0.86 | 0.64 |
EPS (Diluted) | 0.53 | 0.58 | 0.66 | 0.67 | 0.86 | 0.64 |
EPS Growth | -23.12% | -12.12% | -1.49% | -22.09% | 34.38% | 6.67% |
Free Cash Flow | 41.46 | 24.62 | -85.73 | -117.45 | 63.88 | 9.64 |
Free Cash Flow Per Share | 0.26 | 0.15 | -0.52 | -0.71 | 0.48 | 0.08 |
Dividend Per Share | - | - | 0.100 | 0.400 | 0.300 | - |
Dividend Growth | - | - | -75.00% | 33.33% | - | - |
Gross Margin | 12.09% | 13.12% | 12.06% | 12.30% | 12.92% | 12.90% |
Operating Margin | 8.26% | 9.07% | 8.75% | 8.33% | 8.97% | 8.30% |
Profit Margin | 5.93% | 6.83% | 7.33% | 6.50% | 7.09% | 6.41% |
Free Cash Flow Margin | 2.85% | 1.78% | -5.76% | -6.93% | 3.96% | 0.78% |
EBITDA | 199.93 | 196.12 | 163.32 | 175.63 | 178.26 | 130.27 |
EBITDA Margin | 13.73% | 14.15% | 10.97% | 10.36% | 11.05% | 10.55% |
D&A For EBITDA | 79.73 | 70.41 | 33.11 | 34.42 | 33.57 | 27.78 |
EBIT | 120.2 | 125.71 | 130.21 | 141.21 | 144.69 | 102.5 |
EBIT Margin | 8.26% | 9.07% | 8.75% | 8.33% | 8.97% | 8.30% |
Effective Tax Rate | 23.41% | 24.43% | 23.52% | 25.79% | 22.87% | 22.12% |
Revenue as Reported | - | - | 1,488 | 1,695 | 1,613 | 1,234 |
Advertising Expenses | - | - | 0.48 | 0.35 | 0.23 | 0.11 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.